Neuroprotective effects of a novel AMPA receptor antagonist, YM872

NeuroReport

Volumn 9, Issue 7, 1998, Pages 1287-1290

  Small, Daniel L ^a   Murray, Christine L ^a   Monette, Robert ^a   Kawasaki Yatsugi, Sachiko ^b   Morley, Paul ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b ASTELLAS PHARMA INC   (Japan)

Author keywords

AMPA; Confocal microscopy; Cortical culture; Hippocampal slice; In vitro ischemia; Neuroprotection; Quinoxalinediones; YM872

Indexed keywords

2,3 QUINOXALINEDIONE DERIVATIVE; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR ANTAGONIST; GLUCOSE; OXYGEN; UNCLASSIFIED DRUG; [2,3 DIOXO 7 (1H IMIDAZOL 1 YL) 6 NITRO 1,2,3,4 TETRAHYDRO 1 QUINOXALINYL] ACETIC ACID;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN PROTECTION; CELL VIABILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DOSE RESPONSE; HIPPOCAMPUS; MALE; NEPHROTOXICITY; NERVE CELL NECROSIS; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0032507582     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199805110-00005     Document Type: Article

References (10)

1. Gill R. Cerebrovasc Brian Metab Rev 6, 225-256 (1994).
2. Xue D, Huang Z-G, Barnes K et al. J Cerebr Blood Flow Metab 14, 251-261 (1994).
3. Shimizu-Sawamata M. Kawasaki-Yatsugi S, Okada M et al. J Pharmacol Exp Ther 270, 84-92 (1996).
4. Kohara A, Okada M, Tsutsumi R et al. Soc Neurosci Abstr 22, 604.2 (1996).
5. Kawasaki-Yatsugi S, Yatsugi S, Takahashi M et al. J Cerebr Blood Flow Metab 17, S137 (1997).
6. Takahashi M, Ni JW, Kawasaki Yatsugi S et al. J Cerebr Blood Flow Metab 17, S139 (1997).
7. Black MA, Tremblay R, Mealing G et al. J Neurochem 65, 2170-2177 (1995).
8. Monette R, Small DL, Mealing G and Morley P. Brain Res Protocols 2, 99-108 (1998).
9. Small DL, Monette R, Chakravarthy B et al. Neuropharmacology 35, 1037-1048 (1996).
10. Small DL, Monette R, Buchan AM and Morley P. Brain Res 753, 209-218 (1997).